Correlation Between Oculus VisionTech and NeuPath Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oculus VisionTech and NeuPath Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oculus VisionTech and NeuPath Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oculus VisionTech and NeuPath Health, you can compare the effects of market volatilities on Oculus VisionTech and NeuPath Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oculus VisionTech with a short position of NeuPath Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oculus VisionTech and NeuPath Health.

Diversification Opportunities for Oculus VisionTech and NeuPath Health

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Oculus and NeuPath is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Oculus VisionTech and NeuPath Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuPath Health and Oculus VisionTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oculus VisionTech are associated (or correlated) with NeuPath Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuPath Health has no effect on the direction of Oculus VisionTech i.e., Oculus VisionTech and NeuPath Health go up and down completely randomly.

Pair Corralation between Oculus VisionTech and NeuPath Health

Assuming the 90 days horizon Oculus VisionTech is expected to generate 1.17 times less return on investment than NeuPath Health. In addition to that, Oculus VisionTech is 1.37 times more volatile than NeuPath Health. It trades about 0.17 of its total potential returns per unit of risk. NeuPath Health is currently generating about 0.27 per unit of volatility. If you would invest  16.00  in NeuPath Health on September 24, 2024 and sell it today you would earn a total of  4.00  from holding NeuPath Health or generate 25.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Oculus VisionTech  vs.  NeuPath Health

 Performance 
       Timeline  
Oculus VisionTech 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Oculus VisionTech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Oculus VisionTech showed solid returns over the last few months and may actually be approaching a breakup point.
NeuPath Health 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in NeuPath Health are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuPath Health showed solid returns over the last few months and may actually be approaching a breakup point.

Oculus VisionTech and NeuPath Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oculus VisionTech and NeuPath Health

The main advantage of trading using opposite Oculus VisionTech and NeuPath Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oculus VisionTech position performs unexpectedly, NeuPath Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuPath Health will offset losses from the drop in NeuPath Health's long position.
The idea behind Oculus VisionTech and NeuPath Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stocks Directory
Find actively traded stocks across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities